Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Disease Progression 1Cisplatin Nephrotoxicity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 265Magnetic Resonance Spectroscopy 216pembrolizumab 212Carboplatin 173Biopsy 162Cisplatin 155Nivolumab 147Cyclophosphamide 131Paclitaxel 116Radiotherapy 115Gemcitabine 110Bevacizumab 91durvalumab 84Dexamethasone 79Rituximab 74Oxaliplatin 71atezolizumab 67Fluorouracil 66Doxorubicin 65Capecitabine 65Docetaxel 64venetoclax 63Etoposide 63Radiosurgery 58Radiation 57Prednisone 55Ipilimumab 55Cytarabine 55Pemetrexed 54Lenalidomide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Thioctic Acid × 90 days × Clear all
NCT07574684 2026-05-08

ALA /NSCLC

Ain Shams University

Phase 2 Not yet recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Disease Progression

NCT07564479 2026-05-04

Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity

Minia University

Phase 2 Recruiting
50 enrolled

Cisplatin Nephrotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡